These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35640803)

  • 41. Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy.
    Quadri Z; Elsherbini A; Bieberich E
    Pharmacol Res; 2022 Jan; 175():105980. PubMed ID: 34863822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategies for Engineering Exosomes and Their Applications in Drug Delivery.
    Zhu M; Li S; Li S; Wang H; Xu J; Wang Y; Liang G
    J Biomed Nanotechnol; 2021 Dec; 17(12):2271-2297. PubMed ID: 34974854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies.
    Xu M; Feng T; Liu B; Qiu F; Xu Y; Zhao Y; Zheng Y
    Theranostics; 2021; 11(18):8926-8944. PubMed ID: 34522219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence.
    Zhang J; Ma B; Wang Z; Chen Y; Li C; Dong Y
    Cell Commun Signal; 2024 Jan; 22(1):18. PubMed ID: 38195552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins.
    Kim M; Choi H; Jang DJ; Kim HJ; Sub Y; Gee HY; Choi C
    Stem Cells Transl Med; 2024 Jul; 13(7):637-647. PubMed ID: 38838263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exosome engineering in cell therapy and drug delivery.
    Sadeghi S; Tehrani FR; Tahmasebi S; Shafiee A; Hashemi SM
    Inflammopharmacology; 2023 Feb; 31(1):145-169. PubMed ID: 36609717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment.
    Zhao Y; Tan H; Zhang J; Pan B; Wang N; Chen T; Shi Y; Wang Z
    Int J Nanomedicine; 2023; 18():6847-6868. PubMed ID: 38026523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management.
    Loric S; Denis JA; Desbene C; Sabbah M; Conti M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exosome as a Natural Gene Delivery Vector for Cancer Treatment.
    Pofali P; Mondal A; Londhe V
    Curr Cancer Drug Targets; 2020; 20(11):821-830. PubMed ID: 32972340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plant-derived extracellular vesicles -a novel clinical anti-inflammatory drug carrier worthy of investigation.
    Shao M; Jin X; Chen S; Yang N; Feng G
    Biomed Pharmacother; 2023 Dec; 169():115904. PubMed ID: 37984307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracellular vesicle-mediated delivery of molecular compounds into gametes and embryos: learning from nature.
    Barkalina N; Jones C; Wood MJ; Coward K
    Hum Reprod Update; 2015; 21(5):627-39. PubMed ID: 26071427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prospects and challenges of exosomes as drug delivery systems].
    Meng W; Li L; Zhu G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Aug; 37(4):714-720. PubMed ID: 32840090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications.
    Jia Y; Yu L; Ma T; Xu W; Qian H; Sun Y; Shi H
    Theranostics; 2022; 12(15):6548-6575. PubMed ID: 36185597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insight into isolation, identification techniques and medical applications of exosomes.
    Yang XX; Sun C; Wang L; Guo XL
    J Control Release; 2019 Aug; 308():119-129. PubMed ID: 31325471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.